Literature DB >> 7648803

The comparison of four weight reduction strategies aimed at overweight diabetic patients.

R M Manning1, R T Jung, G P Leese, R W Newton.   

Abstract

Four weight reduction strategies were investigated in a diabetic population who previously had shown little motivation to lose weight. Some 409 patients, body mass index 28-45 were invited to participate. Only 51% replied, although 22 patients (5.4%) lost > 3 kg by invitation alone. The study comprised 159 patients, randomly allotted to either regular clinic visits, behavioural group therapy, dexfenfluramine (30 mg d-1 for initial 3 months) or combined home and clinic visits. A further 58 patients were monitored as controls. At 3 months the best weight loss (intention to treat) was achieved using dexfenfluramine with mean weight losses of 1.6, 1.2, 3.4, and 1.7 kg, respectively, in each group. At 1 year weight losses were similar (1.2, 1.8, 2.8, 1.2 kg, respectively) but contrasted with a mean 1.2 kg weight gain in the controls. Some 38% lost > 3 kg on dexfenfluramine compared to 19-23% for the others. In those who completed the study, weight loss was similar with behavioural therapy (3 kg) or dexfenfluramine (3.2 kg). We conclude that intensive dietetic efforts can reverse the weight increase in the diabetic population although weight loss is minimal. Dexfenfluramine was most effective in the short term, behavioural therapy useful long term but only in those who remained within the group; home visits offered no advantage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648803     DOI: 10.1111/j.1464-5491.1995.tb00504.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

Review 1.  Effective management of obesity.

Authors:  S O'Meara; A M Glenny; C Wilson; A Melville; T A Sheldon
Journal:  Qual Health Care       Date:  1997-09

2.  Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.

Authors:  Kirsty Winkley; Rebecca Upsher; Daniel Stahl; Daniel Pollard; Architaa Kasera; Alan Brennan; Simon Heller; Khalida Ismail
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

Review 3.  Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health Care.

Authors:  J D Douketis; J W Feightner; J Attia; W F Feldman
Journal:  CMAJ       Date:  1999-02-23       Impact factor: 8.262

Review 4.  Current concepts in the pharmacological management of obesity.

Authors:  P J Carek; L M Dickerson
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 5.  Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.

Authors:  R Davis; D Faulds
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

6.  Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus.

Authors:  N de Fine Olivarius; A H Andreasen; V Siersma; B Richelsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  2006-07-14       Impact factor: 10.122

Review 7.  Industry funding and the reporting quality of large long-term weight loss trials.

Authors:  O Thomas; L Thabane; J Douketis; R Chu; A O Westfall; D B Allison
Journal:  Int J Obes (Lond)       Date:  2008-08-19       Impact factor: 5.095

Review 8.  Current management strategies for coexisting diabetes mellitus and obesity.

Authors:  Andre J Scheen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.